IBS & irritable bowel — all decisions

The Veteran withdrew his appeal, and the Board dismissed all pending claims.

The Board granted a disability rating of 30 percent but no higher for irritable bowel syndrome (IBS) based on the Veteran's symptoms of severe diarrhea, or alternating diarrhea and constipation, with more or less constant abdominal distress.

The veteran withdrew appeals for service connection for irritable bowel syndrome and bilateral foot skin condition.

The Board denied higher ratings for hypertension and left elbow rheumatoid arthritis, granted a 20 percent rating for dry eye syndrome, and remanded several service connection claims.

The Board denied service connection for irritable bowel syndrome (IBS) and urinary frequency as there is no evidence of a current disability, and the Veteran does not meet the criteria for service connection.

The Board denied service connection for sinusitis, granted a 30% rating for IBS, and granted an effective date of October 3, 2022 for the grant of service connection for IBS. The low back disability and radiculopathy issues were remanded.

The Board granted an initial disability evaluation of 30 percent for irritable bowel syndrome (IBS) effective from the date of claim.

The Veteran is granted a total disability rating based upon individual unemployability due to service-connected disabilities prior to August 28, 2023, and basic eligibility for Dependents' Educational Assistance benefits.

The Board granted service connection for right knee chondromalacia of the patella and denied service connection for bilateral hearing loss. The claims for increased ratings for irritable bowel syndrome (IBS) and bronchitis were also denied, while other claims for service connection and increased ratings were remanded.

The Board remands the claims for service connection for irritable bowel syndrome and gastroesophageal reflux disease to the AOJ for further development, including obtaining a VA examination.

The Board denied service connection for IBS, chronic fatigue syndrome, and increased ratings for bilateral foot conditions and bilateral hearing loss. The TBI, cervical spine, left knee, right knee, lower left extremity neurological condition, lower right extremity neurological condition, and neuropathy of the right ankle residuals were remanded.

The Board denied an increased disability rating for GERD and IBS, finding the current ratings appropriate based on the evidence.

The Board granted an effective date of December 17, 2018, for the award of service connection for other specified trauma disorder and stressor related disorder. Other claims were denied or remanded.

The Board remands the claim for service connection of irritable bowel syndrome (IBS) to obtain a clarifying medical opinion regarding its potential relationship with the Veteran's service-connected major depressive disorder.

The Board denied the veteran's appeal for a higher initial rating and an earlier effective date for his service-connected irritable bowel syndrome.

The Board granted service connection for hemorrhoids as a secondary condition to IBS, denied service connection for fibromyalgia and loss of sense of smell, and denied an increased rating for IBS. The claims for rotator cuff tendonitis and tinea pedis/seborrheic dermatitis were remanded.

The Board granted service connection for irritable bowel syndrome and assigned initial ratings of 30 percent for migraines, 20 percent for each ankle condition, and 40 percent for lumbar strain. Effective dates earlier than July 7, 2022, were denied for the ankle, migraine, and lumbar strain conditions, while an effective date of August 17, 2022, was granted for sinusitis.

The Board denied the claims for earlier effective dates and remanded several service connection claims.

The Board denied service connection for obstructive sleep apnea, headaches, erectile dysfunction, and hypertension. However, it granted service connection for irritable bowel syndrome and hypothyroidism.

The Board granted a 30 percent disability rating for IBS from May 19, 2024, and denied service connection for fibromyalgia, chronic fatigue syndrome, respiratory disorder, heart disability, and bilateral hearing loss.